<DOC>
	<DOCNO>NCT01319435</DOCNO>
	<brief_summary>Phase I , open-label study evaluate pharmacokinetics , tolerability short-term safety ciprofloxacin neonate suspect ( proven ) Gram Negative infection . Objectives : To evaluate multiple-dose pharmacokinetics ciprofloxacin neonate young infant ( 24 - 52 week postmenstrual age ) suspect proven Gram Negative infection . To evaluate tolerability describe short-term safety ciprofloxacin neonates young infant suspect ( prove ) Gram Negative infection . To describe clinical outcome neonate treat ciprofloxacin</brief_summary>
	<brief_title>TINN Pharmacokinetics ( PK ) Study Treat Infections iN Neonates</brief_title>
	<detailed_description>This study part TINN 'Treat Infections Neonates ' comprehensive project evaluate safety ciprofloxacin tolerate neonate . Ciprofloxacin antibiotic use many year newborn baby infant le 3 month old treat bacteria resistant antibiotic . Ciprofloxacin unlicensed age group . The European Medicines Agency WHO prioritise research drug . The TINN consortium aim conduct work require license ( market authorization ) newborn baby infant le 3 month old . The aim study describe newborn baby young infant deal medicine . Blood sample take begin course antibiotic end . A minimal amount blood require ( less half teaspoon ) total collected staff experience blood sample neonate way cause least disruption baby . The level ciprofloxacin blood measure . The level use work quickly body get rid medicine . This allow recommendation best dose often medicine give . We aim recruit 50 neonate infant age 3 month prescribe Ciprofloxacin inpatient suspect proven infection . They recruit 2 year neonatal unit Liverpool Women 's NHS Foundation Trust Alder Hey Children 's NHS Foundation Trust . Consent request baby detailed investigation see genetic factor affect way body handle ciprofloxacin .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>Receiving ciprofloxacin follow clinical decision attend physician Likely survive 48 hour judgement attend physician Ciprofloxacin commence 5th day life</criteria>
	<gender>All</gender>
	<minimum_age>24 Weeks</minimum_age>
	<maximum_age>52 Weeks</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Ciprofloxacin</keyword>
	<keyword>Neonates</keyword>
	<keyword>Gram negative infection</keyword>
</DOC>